These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 28570599)
81. Paricalcitol Attenuates Cardiac Fibrosis and Expression of Endothelial Cell Transition Markers in Isoproterenol-Induced Cardiomyopathic Rats. Lai CC; Liu CP; Cheng PW; Lu PJ; Hsiao M; Lu WH; Sun GC; Liou JC; Tseng CJ Crit Care Med; 2016 Sep; 44(9):e866-74. PubMed ID: 27065465 [TBL] [Abstract][Full Text] [Related]
83. Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway. Zhao T; Kee HJ; Bai L; Kim MK; Kee SJ; Jeong MH Front Pharmacol; 2021; 12():677757. PubMed ID: 33959033 [TBL] [Abstract][Full Text] [Related]
84. [Establishment of a FVB/N mouse model of cardiac hypertrophy by isoprenaline]. Yang CZ; Tian AJ; Meng ZH; Wu JM; Zhang YY; Guo LJ; Li ZJ Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 46(6):906-10. PubMed ID: 25512281 [TBL] [Abstract][Full Text] [Related]
85. MicroRNA-489 suppresses isoproterenol-induced cardiac fibrosis by downregulating histone deacetylase 2. Yang X; Yu T; Zhang S Exp Ther Med; 2020 Mar; 19(3):2229-2235. PubMed ID: 32104288 [TBL] [Abstract][Full Text] [Related]
87. Cryptotanshinone attenuates isoprenaline-induced cardiac fibrosis in mice associated with upregulation and activation of matrix metalloproteinase-2. Ma S; Yang D; Wang K; Tang B; Li D; Yang Y Mol Med Rep; 2012 Jul; 6(1):145-50. PubMed ID: 22505122 [TBL] [Abstract][Full Text] [Related]
89. Endophilin A2 attenuates cardiac hypertrophy induced by isoproterenol through the activation of autophagy. Wang XQ; Xu ZT; Zhang GP; Hou N; Mo QX; Wei J; Jiang X; Liu Y; Luo JD Am J Transl Res; 2019; 11(8):5065-5075. PubMed ID: 31497222 [TBL] [Abstract][Full Text] [Related]
90. Evidence-based mechanistic role of chrysin towards protection of cardiac hypertrophy and fibrosis in rats. Meshram S; Verma VK; Mutneja E; Sahu AK; Malik S; Mishra P; Bhatia J; Arya DS Br J Nutr; 2023 Apr; 129(7):1105-1118. PubMed ID: 35177130 [TBL] [Abstract][Full Text] [Related]
91. Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway. Zhao Y; Jia WW; Ren S; Xiao W; Li GW; Jin L; Lin Y Exp Ther Med; 2021 Aug; 22(2):870. PubMed ID: 34194548 [TBL] [Abstract][Full Text] [Related]
92. Peroxiredoxin 3 Inhibits Cardiac Fibrosis in Mice via NOX4-P38 Signalling. Xiong X; Li J; Chen Z; Luo C; Wei W; Li B; Kang Y; Nong X; Ai F; Zhang J Cell J; 2023 Jun; 25(6):391-398. PubMed ID: 37434456 [TBL] [Abstract][Full Text] [Related]
93. Echocardiographic evaluation of cardiac reserve to detect subtle cardiac dysfunction in mice. Wang X; Wei Z; Wang P; Zhou J; Feng M; Li M; Liu M; Wang J; Zhang X; Gao F; Xing C; Li J Life Sci; 2023 Oct; 331():122079. PubMed ID: 37696487 [TBL] [Abstract][Full Text] [Related]
94. Latent-transforming growth factor β-binding protein 2 accelerates cardiac fibroblast apoptosis by regulating the expression and activity of caspase-3. Shi C; Li X; Hong F; Wang X; Jiang T; Sun B; Li S Exp Ther Med; 2021 Oct; 22(4):1146. PubMed ID: 34504591 [TBL] [Abstract][Full Text] [Related]
95. Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice. Agostinucci K; Grant MKO; Melaku W; Nair C; Zordoky BN Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986490 [TBL] [Abstract][Full Text] [Related]
96. FGF2 modulates cardiac remodeling in an isoform- and sex-specific manner. Nusayr E; Sadideen DT; Doetschman T Physiol Rep; 2013 Sep; 1(4):. PubMed ID: 24244869 [TBL] [Abstract][Full Text] [Related]
97. The influence of gender on cardiac fibrosis induced by sympathetic stimulation. Hori Y; Uechi M; Ebisawa T; Yamano S; Yoshioka K; Mutoh K Chin J Physiol; 2008 Jun; 51(3):146-51. PubMed ID: 18935909 [TBL] [Abstract][Full Text] [Related]
98. Mouse models for the study of postnatal cardiac hypertrophy. Del Olmo-Turrubiarte A; Calzada-Torres A; Díaz-Rosas G; Palma-Lara I; Sánchez-Urbina R; Balderrábano-Saucedo NA; González-Márquez H; Garcia-Alonso P; Contreras-Ramos A Int J Cardiol Heart Vasc; 2015 Jun; 7():131-140. PubMed ID: 28785661 [TBL] [Abstract][Full Text] [Related]
99. Gold Nanoparticles for Targeting the Fibrotic Heart: A Probe Indicating Vascular Permeability. Yang C; Tian A; Wu J; Meng Z; Zhang Y; Nie G; Li Z J Nanosci Nanotechnol; 2019 Dec; 19(12):7546-7550. PubMed ID: 31196259 [TBL] [Abstract][Full Text] [Related]
100. Are Murine Fibroblasts Responsible for Fibrosis Reversion? Comment on the Article by Luchetti et al. Henrot P; Truchetet ME; Cario-Andre M Arthritis Rheumatol; 2017 Aug; 69(8):1703. PubMed ID: 28464512 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]